#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neutropenia Lennox-Gastaut syndrome Ependymoma Leukoencephalopathy Biliary neoplasm Anti-glomerular basement membrane disease Pancreatic neuroendocrine tumour Ventricular tachycardia Squamous cell carcinoma of the cervix Lymphangioma Atypical haemolytic uraemic syndrome Metastases to peritoneum Ewing's sarcoma metastatic Gastric cancer Acute on chronic liver failure More trials…

    Learn about Rare Diseases

    Leukoencephalopathy – Life with Disease Choroid melanoma – Life with Disease Waldenstrom’s macroglobulinaemia – Diagnostics Friedreich’s ataxia Castleman’s disease – Diagnostics Hypereosinophilic syndrome Nephroblastoma – Basic Information Mucopolysaccharidosis I X-linked lymphoproliferative syndrome – Life with Disease Mantle cell lymphoma stage II More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Basimglurant Sodium Butyrate Triptorelin Acetate GSKVX000000048111 Sodium Iodide L-LEUCINE GSKVX000000034792 Elacestrant [89Zr]Bms-986279 Iopamidol Paracetamol Dc Vancomycin Hydrochloride Dasatinib Nitrofurantoin Abbv-668 Hu5F9‐G4 ARFOLITIXORIN Mps-214 Histamine Dihydrochloride Eltrombopag More therapies…

    Learn about Your Condition

    Burning mouth syndrome Haemodialysis Endometrial cancer stage IV Hepato-lenticular degeneration Bronchitis Orthostatic hypotension Thrombocytosis Pouchitis Diabetic nephropathy Mechanical ventilation Breast cancer recurrent Syphilis Brain injury Portal hypertension Apathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Narcolepsy

  • Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 2

    Recruiting

    3 1
    Investigated Diseases:
    • Narcolepsy
    Investigated Drugs:
    • Alks 2680
    Belgium France Germany Italy The Netherlands Spain

  • Phase 3 Randomized Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 1

    Recruiting

    3 1
    Investigated Diseases:
    • Narcolepsy
    Investigated Drugs:
    • Alks 2680
    Belgium France Italy The Netherlands Spain

  • Long-term Safety Study of ORX750 for Patients with Narcolepsy and Idiopathic Hypersomnia Who Completed a Previous ORX750 Trial

    Recruiting

    4 1 1
    Investigated Diseases:
    • Hypersomnia
    • Narcolepsy
    Investigated Drugs:
    • ORX750
    France Italy Spain

  • A Study to Test the Safety and Effectiveness of TAK-360 in People with Narcolepsy without Cataplexy

    Recruiting

    2 1
    France Italy Spain

  • Study on the Safety and Effects of ORX750 for Patients with Narcolepsy and Idiopathic Hypersomnia

    Recruiting

    2 1
    Investigated Drugs:
    • ORX750
    France Italy Spain

  • Long-Term Study on the Safety and Effects of ALKS 2680 for Patients with Narcolepsy Type 1 and Type 2

    Recruiting

    4 1 1
    Investigated Diseases:
    • Hypersomnia
    • Narcolepsy
    Investigated Drugs:
    • Alks 2680
    Belgium Czechia France Italy The Netherlands Spain
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!